Related Experiment Video
Updated: Aug 6, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
[Antiglaucoma drugs--content of preservatives and the patient's compliance]
1Ocní oddelení UVN--Ocní klinika 1 LF UK a UVN, Praha. VybornyP@seznam.cz
Abstract:
The presence of preservatives in eye drops, may have, depending on the concentration, cytotoxic influence on the corneal and conjunctival cells, and may cause the patients' subjective inconveniences. The authors compare the benzalconium chloride (BAC) concentrations in individual drug used for glaucoma treating. The daily dose of BAC was calculated according to the drop's size and BAC concentration. The daily dose of BAC differs depending on the selected therapy markedly--doses in the range from 0 to 10 micrograms were found. The BAC concentration is one of important factors affecting the patient's compliance in the treatment of the primary open angle glaucoma.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Cholinergic Antagonists: Pharmacokinetics
Drug Dosing: Geriatric Patients
Drug Therapy
Antianxiety Medications